The GLP-1 obesity home delivery injectables market in Germany is growing at a CAGR of 13.0%, driven by rising prescription use of GLP-1 therapies and increasing acceptance of home-based medication delivery
Eli Lilly, which manufacturers both Zepbound and Mounjaro, states that for the first four weeks of using Zepbound and the four weeks after each dose increase, people should use a barrier method of birth control (such as condoms or a cervical cap) to prevent pregnancy, or switch to alternative non-oral contraceptive, such as an IUD
Hypoglycaemia: When used alongside insulin or sulfonylureas, there is an increased risk of low blood sugar
If you receive a positive pregnancy test, please stop all medications immediately and contact us so we can guide you through the next steps
GLP-1 Drugs Fail to Provide Key Weight-Loss Benefit Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in heart and lung function essential for long-term good health, University of Virginia experts warn in a new paper